Amyloidosis, a disorder of protein metabolism identified by extracellular deposition of fibrils, is associated with aging and/or plasma cell dyscrasias like multiple myeloma. Tissue destruction, cell loss and pain are the inevitable results of amyloid accumulation. Immunoglobulin light (L) chains are the most common precursors of fibrils (AL amyloidosis). The principle aims of this proposal are to enlarge the database of three-dimensional structures of amyloidogenic antibody proteins, or fragments therefrom, and to determine the general features of the protein precursors of amyloid fibrils, and identify what makes them so destructive. Since the principal investigator has solved the crystal structures of seven conformational isomers of a l-type L chain from a patient (Mcg) with amyloidosis, it will serve as the prototypic amyloidogenic protein to model self assembly of precursors into fibrils. The structures of two additional amyloidogenic L chains, one l- and one k-type, will also be determined by X-ray crystallography and compared with the Mcg prototype. Heterologous (hybrid) dimers of Mcg and other L chains can be engineered to give structures and binding properties distinctly different from their progenitor molecules, but will also provide information about common intermolecular association motifs. Immunoglobulin heavy (H) chains can also be involved in amyloid formation (AH amyloidosis). However, in two immunoglobulins included in this study (Mcg IgG1 and Yvo IgM) the H chains caused different types of pathology. Their variable (VH) domains contributed to the formation of intravascular aggregates which in turn led to hyperviscosity and petechiae. Even when degraded with enzymes, the VH domains yielded peptides that were insoluble in aqueous solvents. Sequencing of the Mcg VH required innovative use of detergents and polyacrylamide gels, technology which will now be transferred to the Yvo VH problem. These sequences are essential for completing the X-ray analyses of the intact Mcg IgG1 and the Yvo antigen binding fragment (Fab).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA072803-01
Application #
2010867
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1997-02-01
Project End
2001-01-31
Budget Start
1997-02-01
Budget End
1998-01-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Manion, Carl V; Hochgeschwender, Ute; Edmundson, Allen B et al. (2011) Dietary aspartyl-phenylalanine-1-methyl ester delays osteoarthritis and prevents associated bone loss in STR/ORT mice. Rheumatology (Oxford) 50:1244-9
Ramsland, Paul A; Terzyan, Simon S; Cloud, Gwendolyn et al. (2006) Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody. Biochem J 395:473-81
Bourne, Philip C; Terzyan, Simon S; Cloud, Gwendolyn et al. (2004) Three-dimensional structures of a humanized anti-IFN-gamma Fab (HuZAF) in two crystal forms. Acta Crystallogr D Biol Crystallogr 60:1761-9
Terzyan, Simon; Ramsland, Paul A; Voss Jr, Edward W et al. (2004) Three-dimensional structures of idiotypically related Fabs with intermediate and high affinity for fluorescein. J Mol Biol 339:1141-51
Terzyan, Simon S; Bourne, Christina R; Ramsland, Paul A et al. (2003) Comparison of the three-dimensional structures of a human Bence-Jones dimer crystallized on Earth and aboard US Space Shuttle Mission STS-95. J Mol Recognit 16:83-90
Bourne, Philip C; Ramsland, Paul A; Shan, Lin et al. (2002) Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties. Acta Crystallogr D Biol Crystallogr 58:815-23
Shaw, Denis C; Shultz, Brandon B; Ramsland, Paul A et al. (2002) Dealing with intractable protein cores: protein sequencing of the Mcg IgG and the Yvo IgM heavy chain variable domains. J Mol Recognit 15:341-8
Yuriev, E; Ramsland, P A; Edmundson, A B (2002) Recognition of IgG-derived peptides by a human IgM with an unusual combining site. Scand J Immunol 55:242-55
Marchalonis, J J; Adelman, M K; Robey, I F et al. (2001) Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans. J Mol Recognit 14:110-21
Manion, C V; Howard, J; Ogle, B et al. (2001) Aspartame effect in sickle cell anemia. Clin Pharmacol Ther 69:346-55

Showing the most recent 10 out of 27 publications